Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000942794-00-000014
Filing Date
2000-04-24
Accepted
2000-04-24 00:00:00
Documents
2
Period of Report
2000-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q 22799
2 EX-27 2264
  Complete submission text file 0000942794-00-000014.txt   26759
Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address 175 CROSSING BLVD BIOTECHNOLOGY RESEARCH PARK FRAMINGHAM MA 01702 5087975777
AQUILA BIOPHARMACEUTICALS INC (Filer) CIK: 0000704292 (see all company filings)

EIN.: 043307818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12081 | Film No.: 607433
SIC: 2835 In Vitro & In Vivo Diagnostic Substances